|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3865514 |
| (13) | Kind of document | T |
| (96) | European patent application number | 21153365.8 |
| Date of filing the European patent application | 2016-08-01 | |
| (97) | Date of publication of the European application | 2021-08-18 |
| (45) | Date of publication and mention of the grant of the patent | 2026-02-11 |
| (46) | Date of publication of the claims translation | 2026-05-11 |
| (30) | Number | Date | Country code |
| 201562199930 P | 2015-07-31 | US | |
| 201662290896 P | 2016-02-03 | US |
| (72) |
Raum, Tobias , DE
Kufer, Peter , DE
Pendzialek, Jochen , DE
Bluemel, Claudia , DE
Dahlhoff, Christoph , DE
Hoffmann, Patrick , DE
Lutterbuese, Ralf , DE
Nahrwold, Elisabeth , DE
|
| (73) |
Amgen Research (Munich) GmbH ,
Staffelseestrasse 2, 81477 München,
DE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Bispesifinis antikūnas, besirišantis su DLL3 ir CD |
| BISPECIFIC ANTIBODY BINDING DLL3 AND CD3 |